LECONASIA
Skip to content
  • Home
  • About
  • Testimonials
  • News
  • Contact

From the Bench to Biotech Venture Capital – Newswise

Posted on December 18, 2021 by admin
From the Bench to Biotech Venture Capital  Newswise
Bookmark the permalink.

Post navigation

← Super Money Moves: Philly’s top investment rounds of 2021, its best year for VC dollars yet – Technical.ly
Why Venture Capital Investors Are Focused on Femtech – Sidley Austin LLP →

Recent Posts

  • Sequoia Capital reportedly raising two funds, and despite slower VC environment, it’s not alone – TechCrunch
  • Startup Founders Say Venture-Capital Investors Are Driving Harder Deals – The Wall Street Journal
  • As the global venture capital market slows, Africa charts its own course – TechCrunch
  • MaC Venture Capital Raises $203M Fund II – FinSMEs
  • Substack cuts 13 jobs to avoid raising more venture capital – TechCrunch
  • A Rolling Fund May Be Just What Women And BIPOC Venture Capitalists Need To Raise Funding – Forbes
  • How venture capital teams can optimize success in cybersecurity – VentureBeat
  • Venture Capital Q2 Data to Hit Lowest Level Since 2020 – Bloomberg
  • Majority Black-owned MaC Venture Capital raises $203 mln in second fund – Yahoo Finance
  • The new Palo Alto? Europe’s VC scene is heating up as unicorns surge in the region – Fortune
Singapore Office:
21 Bukit Batok Crescent
#09-79 WCEGA Tower
Singapore 658065
Korea Office:
1432 Seocho LG Eclat Banpo-daero
14-gil 71, Seocho-gu Seoul,
Republic of Korea
For Regional Support:
[email protected]

For Sales & Marketing:
[email protected]

LECON ASIA
Copyrights © 2015
All Rights Reserved

www.leconasia.com

Zerif Lite developed by ThemeIsle